Department of Cardiology, Amsterdam University Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Netherlands Heart Institute, Utrecht, The Netherlands.
Curr Heart Fail Rep. 2024 Apr;21(2):147-161. doi: 10.1007/s11897-024-00649-x. Epub 2024 Feb 16.
Guideline-directed medical therapy (GDMT) underuse is common in heart failure (HF) patients. Digital solutions have the potential to support medical professionals to optimize GDMT prescriptions in a growing HF population. We aimed to review current literature on the effectiveness of digital solutions on optimization of GDMT prescriptions in patients with HF.
We report on the efficacy, characteristics of the study, and population of published digital solutions for GDMT optimization. The following digital solutions are discussed: teleconsultation, telemonitoring, cardiac implantable electronic devices, clinical decision support embedded within electronic health records, and multifaceted interventions. Effect of digital solutions is reported in dedicated studies, retrospective studies, or larger studies with another focus that also commented on GDMT use. Overall, we see more studies on digital solutions that report a significant increase in GDMT use. However, there is a large heterogeneity in study design, outcomes used, and populations studied, which hampers comparison of the different digital solutions. Barriers, facilitators, study designs, and future directions are discussed. There remains a need for well-designed evaluation studies to determine safety and effectiveness of digital solutions for GDMT optimization in patients with HF. Based on this review, measuring and controlling vital signs in telemedicine studies should be encouraged, professionals should be actively alerted about suboptimal GDMT, the researchers should consider employing multifaceted digital solutions to optimize effectiveness, and use study designs that fit the unique sociotechnical aspects of digital solutions. Future directions are expected to include artificial intelligence solutions to handle larger datasets and relieve medical professional's workload.
在心力衰竭(HF)患者中,指南指导的医学治疗(GDMT)的应用不足较为常见。数字解决方案具有支持医疗专业人员在不断增长的 HF 患者群体中优化 GDMT 处方的潜力。我们旨在综述当前关于数字解决方案在优化 HF 患者 GDMT 处方方面有效性的文献。
我们报告了关于 GDMT 优化的数字解决方案的功效、研究特征和研究人群。讨论了以下数字解决方案:远程咨询、远程监测、心脏植入式电子设备、嵌入电子健康记录中的临床决策支持,以及多方面干预。数字解决方案的效果在专门的研究、回顾性研究或其他重点研究中进行了报道,这些研究也对 GDMT 的使用进行了评论。总体而言,我们看到更多研究数字解决方案的报告称,GDMT 的使用显著增加。然而,研究设计、使用的结果和研究的人群存在很大的异质性,这阻碍了对不同数字解决方案的比较。讨论了障碍、促进因素、研究设计和未来方向。仍然需要精心设计的评估研究来确定数字解决方案在 HF 患者 GDMT 优化中的安全性和有效性。基于本综述,在远程医疗研究中应鼓励测量和控制生命体征,应积极提醒专业人员注意 GDMT 不达标,研究人员应考虑采用多方面的数字解决方案以提高效果,并采用适合数字解决方案独特社会技术方面的研究设计。未来的方向预计将包括人工智能解决方案,以处理更大的数据集并减轻医疗专业人员的工作负担。